Remove 2028 Remove 3D printing Remove Process control
article thumbnail

Environmental Compliance and Pharmaceutical Quality Standards Pave the Way for Transformational Growth in Chromatography

Frost & Sullivan Manufacturing

The expanding use of chromatography in pharmaceuticals, especially in drug development and clinical research, coupled with the food and beverage industry’s heavy reliance on chromatography for quality control, is expected to accelerate market expansion to $6.60 billion in 2028. The top four companies currently control 64.3%

article thumbnail

Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs

Additive Manufacturing

Stratasys is a leader in polymer 3D printing solutions. CollPlant is a pioneering regenerative and aesthetics medicine company developing innovative technologies and products based on its plant-based collagen for tissue regeneration and organ manufacturing.